Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone-Reference-Cited by-同舟云学术

Serious Adverse Events and Laboratory Monitoring Regimens for Outpatient Parenteral Antimicrobial Therapy With Cefazolin and Ceftriaxone

Published:2023-12-01 Issue:12 Volume:10 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Sunagawa Shawnalyn W¹²,Arduser Sarah¹²,Miller Molly M¹^ORCID,Lyden Elizabeth³,LeMaster Melissa¹,Cortes-Penfield Nicolas⁴,Hankins Richard J⁴,Bergman Scott J¹²^ORCID,Alexander Bryan T¹^ORCID

Affiliation:

1. Department of Pharmaceutical and Nutrition Care, Nebraska Medicine , Omaha, Nebraska , USA

2. College of Pharmacy, University of Nebraska Medical Center , Omaha, Nebraska , USA

3. College of Public Health, University of Nebraska Medical Center , Omaha, Nebraska , USA

4. Divison of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska , USA

Abstract

Abstract The optimal laboratory monitoring frequency for outpatient parenteral antimicrobial therapy–related adverse events (OPAT-AEs) during cefazolin and ceftriaxone therapy is not well defined. We identified 2.7 OPAT-AEs per 1000 sets of weekly laboratory tests in this population, suggesting that less intensive laboratory monitoring may be safe and reasonable.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad606/53976266/ofad606.pdf

Reference12 articles.

1. Outpatient parenteral antimicrobial therapy today;Paladino;Clin Infect Dis,2010

2. Willingness to pay to assess patient preferences for therapy in a Canadian setting;Marra;BMC Health Serv Res,2005

3. 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy;Norris;Clin Infect Dis,2019

4. Evolution of outpatient parenteral antibiotic therapy;Poretz;Infect Dis Clin North Am,1998

5. Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy;Keller;Clin Infect Dis,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time for Outpatient Parenteral Antimicrobial Therapy (OPAT) Coordination: Difficult to Quantify Due to Heterogeneity in OPAT Care Models;Clinical Infectious Diseases;2024-08-19